Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Astex Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01685268
First received: August 31, 2012
Last updated: September 6, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 8, 2016